<DOC>
	<DOCNO>NCT00933673</DOCNO>
	<brief_summary>The purpose study evaluate efficacy tolerability combination chemotherapy L-asparaginase plus DICE regimen patient early stage NK/T-cell lymphoma .</brief_summary>
	<brief_title>New Combination Regimen L-asparaginase , Dexamethasone , Ifosfamide , Cisplatin Etoposide NK/T-Cell Lymphoma</brief_title>
	<detailed_description>DICE regimen find highly effective induction chemotherapy patient early stage NK/T-cell lymphoma ongoing study . L-asparaginase , agent unique anti-cancer mechanism , also find effective salvage set . In term non-overlapped efficacy toxicity , investigator design phase II study verify efficacy tolerability new combination .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , T-Cell</mesh_term>
	<mesh_term>Asparaginase</mesh_term>
	<criteria>Age range 1475 year old Histological confirm , previously untreated stage I/II NK/T cell lymphoma upperaerodigestive tract ECOG performance status le 2 Life expectancy 3 month Normal laboratory value : hemoglobin &gt; 80 g/dl , neutrophil &gt; 2×109/L , platelet &gt; 100×109/L , serum creatine &lt; 1.5×upper limitation normal ( ULN ) , serum bilirubin &lt; 1.5×ULN , ALT AST &lt; 2.5×ULN Pregnant lactate woman Serious uncontrolled disease intercurrent infection The evidence CNS metastasis History malignancy except cure basal cell carcinoma skin carcinoma insitu uterine cervix</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>NK/T cell lymphoma</keyword>
	<keyword>DICE</keyword>
	<keyword>L-asparaginase</keyword>
</DOC>